Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
XBB.1.43.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBB.1.43.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
EU.1.1.3NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
EU.1.1.3NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
EU.1.1.3NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
XBB.1.5.18NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
XBB.1.5.18NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.507NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.507NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.507NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.178NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.178NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.178NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.273NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.273NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.273NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.211NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.211NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.211NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.474NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.474NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.474NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.160.14NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.160.14NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.160.14NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.297NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.1.297NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.297NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
AH.2NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
AH.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
AH.2NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.280NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.1.280NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.280NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.597NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.597NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.597NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.177.45NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.177.45NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.177.45NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.177.72NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.177.72NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.177.72NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.177.43NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.177.43NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.177.43NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.177.85NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.177.85NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.177.85NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
AY.66 (Delta)NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used